What's New
- Updated: Non-resident Pharmacy: List of Approved Inspection Programs (PDF) – effective October 1, 2024, nonresident pharmacy applicants need to meet the requirements specified in this directive.
- Statement on Compounding Semaglutide – approved on August 24, 2024. See this statement from the commission to learn more.
- Ancillary Utilization Plans and the Administration of Drugs and Devices Guidance Document Revised (PDF)
- New Inspection Areas - see our recent announcement
- Guidance on Electronic Prescriptions and Cyberattacks
- COVID-19 Vaccine Guidance from DOH
- Emergent Drug Shortages – The Pharmacy Commission is aware of several drug shortages that have had a deleterious impact on patient care, including shortages affecting certain chemotherapy drugs. See this statement from the commission about the shortages.
- Guidance on Mifepristone from the Pharmacy Commission
Helpful Contact Information
| Personnel Licensing | Email hsqareview2@doh.wa.gov 360-236-4986 |
Pharmacy intern, pharmacists, pharmacy technicians, pharmacy assistants, pharmacy technician-in-training enrollment forms |
| Facilities Licensing | Email hsqafc@doh.wa.gov 360-236-4985 |
All pharmaceutical firms, ancillary utilization plans (AUP), technician training programs (TTP), collaborative drug therapy agreements (CTDA), and change of responsible pharmacist manager forms |
| Background Check Unit (Office of Customer Service) | Email hsqafb@doh.wa.gov | |
| Renewals (Office of Customer Service) | Email hsqarenewalresearch@doh.wa.gov | |
| Call Center (Office of Customer Service) |
Email hsqafc@doh.wa.gov |
|
| Pharmacy Commission Staff | Email wspqac@doh.wa.gov 360-236-4946 |